Renalytix plc (RNLXY) Total liabilities 2020–2024
Renalytix plc (RNLXY) total liabilities at each fiscal year-end, per SEC filings.
$15.8MFY2024 · since FY2020: $5.0M → $15.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $15.8M | -33.1% |
| FY2023 | $23.7M | +21.6% |
| FY2022 | $19.5M | +173.5% |
| FY2021 | $7.1M | +43.1% |
| FY2020 | $5.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RNLXY financial trends
RNLXY RevenueRNLXY Net incomeRNLXY Net marginRNLXY Gross profitRNLXY Gross marginRNLXY Operating incomeRNLXY Operating marginRNLXY Operating cash flowRNLXY Free cash flowRNLXY Capital expendituresRNLXY Return on equityRNLXY Stock buybacksRNLXY Dividends paidRNLXY Total assetsRNLXY Shareholders’ equityRNLXY overview →